![]() |
Volumn 9, Issue 11 Suppl 4, 2007, Pages 4-10
|
Pathophysiology of target-organ disease: does angiotensin II remain the key?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN II;
ANGIOTENSIN RECEPTOR ANTAGONIST;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DRUG DERIVATIVE;
LOSARTAN;
RENIN;
TETRAZOLE DERIVATIVE;
VALINE;
VALSARTAN;
ANIMAL;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
DISEASE COURSE;
DRUG EFFECT;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
REVIEW;
STROKE;
TREATMENT OUTCOME;
ANGIOTENSIN II;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANIMALS;
BLOOD PRESSURE;
CALCIUM CHANNEL BLOCKERS;
CARDIOVASCULAR DISEASES;
DISEASE PROGRESSION;
HUMANS;
HYPERTENSION;
LOSARTAN;
MYOCARDIAL INFARCTION;
RENIN;
RENIN-ANGIOTENSIN SYSTEM;
STROKE;
TETRAZOLES;
TREATMENT OUTCOME;
VALINE;
|
EID: 38449095757
PISSN: 15246175
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1524-6175.2007.07720.x Document Type: Review |
Times cited : (9)
|
References (25)
|